Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | May 28, 2026 | June 01, 2026 |
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CASTLE BIOSCIENCES INC
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,766 |
Reported balance
After 2026-05-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 11,766 · Balance 11,766 F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant.
MIMEDX GROUP, INC.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,510 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 50,913 · Balance 108,510 F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BIOTELEMETRY, INC.
Report date February 09, 2021 · Filed February 11, 2021
Section 16 reporting ended · disclosed 2021-02-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 1
1 source rowRow 1 · 2021-02-09 · Disposition to issuer · Disposed 6,642 · Balance 0 F1: Represents restricted stock units that, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive $72.00 per share in cash, less any applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive $72.00 per share in cash, less any applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 11:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 50,913 | $3.64 | $185,323.32 |
DisclosureSEC source: 0001376339-26-000040 · wk-form4_1781278034.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,510 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 20:48 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 11,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-039569 · wk-form4_1780346927.xml · derivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,766 Underlying: Common Stock · 11,766 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. F2 · derivative.expiration_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:17 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 13,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-038473 · wk-form4_1779913062.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. F2 · derivative.expiration_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:17 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 13,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-038473 · wk-form4_1779913062.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 18:34 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 28,609 | $6.47 | $185,100.23 |
DisclosureSEC source: 0001376339-25-000064 · wk-form4_1750718091.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,597 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:12 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 13,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-25-000076 · wk-form4_1748031161.xml · derivative · entry 3 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,667 Underlying: Common Stock · 13,667 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. F3 · derivative.expiration_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:12 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 8,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-25-000076 · wk-form4_1748031161.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 23, 2025, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. F2 · derivative.expiration_date: The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 23, 2025, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:12 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 8,673 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-25-000076 · wk-form4_1748031161.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:13 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantStock option (right to buy) · Derivative | 3,379 | $0.00 Strike: $71.22 | $0.00 |
DisclosureSEC source: 0001447362-24-000104 · wk-form4_1720037579.xml · derivative · entry 4 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,379 Underlying: Common Stock · 3,379 shares Expires 2034-07-01 Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:13 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 830 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000104 · wk-form4_1720037579.xml · derivative · entry 3 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 830 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:13 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 830 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000104 · wk-form4_1720037579.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 830 Underlying: Common Stock · 830 shares Expires not disclosed F1 · derivative.exercise_price: Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:13 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000104 · wk-form4_1720037579.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 16:15 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 28,988 | $7.26 | $210,452.88 |
DisclosureSEC source: 0001376339-24-000045 · wk-form4_1717704918.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,988 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:37 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 8,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000088 · wk-form4_1717015025.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,636 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant on May 25, 2024. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant on May 25, 2024. Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:37 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 8,636 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000088 · wk-form4_1717015025.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 8,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000080 · wk-form4_1716927040.xml · derivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,673 Underlying: Common Stock · 8,673 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU's vest in full on the one-year anniversary of the date of grant on May 23, 2025. F2 · derivative.expiration_date: The RSU's vest in full on the one-year anniversary of the date of grant on May 23, 2025. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:36 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 487 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000068 · wk-form4_1715718983.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 487 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022. F2 · derivative.expiration_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:36 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000068 · wk-form4_1715718983.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:33 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 3,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-23-000099 · wk-form4_1686083574.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,825 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:33 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 3,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-23-000099 · wk-form4_1686083574.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:57 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 8,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-23-000092 · wk-form4_1685483847.xml · derivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,636 Underlying: Common Stock · 8,636 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024. F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:14 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 487 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-23-000073 · wf-form4_168392242193165.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487 Underlying: Common Stock · 487 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022. F2 · derivative.expiration_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:14 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-23-000073 · wf-form4_168392242193165.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 21:48 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | PurchaseCommon Stock | 1,162 | $21.50 | $24,983.00 |
DisclosureSEC source: 0001447362-22-000182 · wf-form4_166993116671372.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,968 Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 23:21 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 3,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-22-000106 · wf-form4_165455767863784.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,825 Underlying: Common Stock · 3,825 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on June 2, 2023. F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on June 2, 2023. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 23:21 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantStock option (right to buy) · Derivative | 7,647 | $0.00 Strike: $20.77 | $0.00 |
DisclosureSEC source: 0001447362-22-000106 · wf-form4_165455767863784.xml · derivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,647 Underlying: Common Stock · 7,647 shares Expires 2032-06-01 Read SEC document |
| May 12, 2022 Filed Jul 7, 2022 23:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | PurchaseCommon Stock | 220 | $18.77 | $4,129.40 |
DisclosureSEC source: 0001447362-22-000121 · wf-form4_165723586747906.xml · nonDerivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,806 Read SEC document |
| May 12, 2022 Filed Jul 7, 2022 23:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | PurchaseCommon Stock | 1,100 | $18.76 | $20,636.00 |
DisclosureSEC source: 0001447362-22-000121 · wf-form4_165723586747906.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,586 Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:25 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 486 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-22-000087 · wf-form4_165238710755304.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974 Underlying: Common Stock · 486 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022. F2 · derivative.expiration_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:25 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-22-000087 · wf-form4_165238710755304.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:14 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-21-000112 · wf-form4_162085048170377.xml · derivative · entry 2 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460 Underlying: Common Stock · 1,460 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on May 10, 2022. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on May 10, 2022. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:14 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantStock option (right to buy) · Derivative | 5,936 | $0.00 Strike: $54.78 | $0.00 |
DisclosureSEC source: 0001447362-21-000112 · wf-form4_162085048170377.xml · derivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,936 Underlying: Common Stock · 5,936 shares Expires 2031-05-09 F1 · derivative.exercise_date: One-third of the shares shall vest on May 10, 2022, and the remaining shares shall vest in 24 equal monthly installments thereafter. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:30 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerCommon Stock | 6,642 | $72.00 | $478,224.00 |
DisclosureSEC source: 0000899243-21-006129 · doc4.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents restricted stock units that, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive $72.00 per share in cash, less any applicable withholding taxes. Read SEC document |
| May 11, 2020 Filed May 13, 2020 17:29 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 3,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001574774-20-000080 · wf-form4_158940535250854.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,642 F1 · shares: Grant of restricted stock units that, subject to certain exceptions, will vest in full on the first anniversary of the grant date. Read SEC document |
| May 03, 2019 Filed May 7, 2019 18:14 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 3,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001574774-19-000045 · wf-form4_155726727658812.xml · nonDerivative · entry 1 Olson Tiffany · CIK 0001442172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,007 F1 · shares: Grant of restricted stock units that, subject to certain exceptions, will vest in full on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.